Equimed Pharma Bridge is AI Enabled Platform for accelerating entry of your idea

Strategic Solutions Across the Biopharma Lifecycle

Equimed Alliance aligns your regulatory, IP, CMC, and commercialization decisions to accelerate U.S. market readiness

AI enabled US Market Assessment & Entry

Market feasibility, competitive landscape, and opportunity assessment
FDA pathway identification and approval strategy
Commercial readiness and go-to-market planning

Idea to Commercialization

InsightX derived pathway
Development and scale-up strategy aligned with US regulatory expectations
Integrated regulatory, CMC, and commercialization planning
Decision support across critical development and launch milestones

Regulatory Strategy

NDA, ANDA, 505(b)(2), and DMF regulatory pathways
Submission planning, regulatory writing, and filing support
FDA interaction management, including responses to agency queries

IP Strategy

IP landscape assessment and freedom-to-operate analysis
Exclusivity and lifecycle management strategies
Alignment of regulatory and IP approaches to strengthen long-term protection

Expert Opinions

Advisory support from experienced pharmaceutical scientists and leaders
Troubleshooting complex formulation, development, and scale-up challenges
Practical insights grounded in real-world regulatory and commercialization experience

Partners

Who We Serve

Biosimilars and Biologics

Supporting development and regulatory strategy for biosimilars and complex biologic products.

Speciality and complex generics

Advising on regulatory pathways for complex formulations and value-added generic products.

International biopharma innovators

Helping global innovators navigate FDA pathways and prepare for successful U.S. market entry.

Pharmaceutical manufacturers

Collaborating with manufacturers and CMOs to ensure compliance, quality, and regulatory alignment.

Research and early stage innovators

Partnering with emerging companies to build a strong regulatory and commercial foundation.